| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ligand Pharmaceuticals Inc (LGND) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 20 sells. LGND is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 161.3K | $35.72M | - | |
| Dir | 44.0K | $9.74M | - | |
| Dir | 33.8K | $7.48M | - | |
| Dir | 32.8K | $7.25M | - | |
| Other | 30.8K | $6.82M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2016 | Berkman Charles S81 | VP, Gen. Counsel &Secretary | Sale+OE | 22,067 | $123.16 | $2,717,771.72 | -19.9% | |
| Aug 5, 2016 | Foehr Matthew W72 | President And COO | Sale+OE | 12,500 | $122.14 | $1,526,750.00 | -13.7% | |
| Aug 1, 2016 | Kozarich John W61 | Director | Sell | 1,000 | $137.57 | $137,569.00 | -0.6% | |
| Jul 1, 2016 | Kozarich John W61 | Director | Sell | 1,000 | $121.40 | $121,402.00 | -0.8% | |
| Jun 1, 2016 | Kozarich John W61 | Director | Sell | 1,000 | $117.42 | $117,419.00 | -1.1% | |
| May 18, 2016 | Herman Melanie J | Director Of Accounting | Sell | 334 | $120.50 | $40,247.00 | -9.2% | |
| May 6, 2016 | Aryeh Jason | Director | Sell | 25,000 | $119.20 | $2,979,954.00 | -5.4% | |
| May 2, 2016 | Kozarich John W61 | Director | Sell | 1,000 | $121.57 | $121,568.00 | -1.1% | |
| Apr 6, 2016 | Kozarich John W61 | Director | Sell | 5,000 | $115.00 | $575,000.00 | -10.1% | |
| Mar 17, 2016 | Foehr Matthew W72 | President And COO | Sale+OE | 6,400 | $96.70 | $618,880.00 | -7.7% |